Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00083733 · ClinicalTrials.gov registry record
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 216
- Enrollment target
NCT00083733: Completed study, sponsored by National Cancer Institute (NCI).
NCT00083733 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 216 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00083733 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 216 participants
- Enrollment target
Study Summary
This study will collect, analyze, and compare genes and proteins in normal breast tissue with those in various tissues from women with breast cancer to look for changes that are unique to breast cancer cells. Information about these differences may lead to more effective breast cancer treatments with fewer side effects. The study has the following objectives: * To define the molecular (genetic and protein) profile of normal breast tissue from pre- and post-menopausal women of different ages and who have had varying numbers of children (or no children), and who are in different phases of the menstrual cycle * To define the molecular profile of primary breast tumors and tumors that have metastasized (spread) beyond the primary site * To characterize breast cancer stem cells and establish cell lines from the pleural fluid (fluid around the lungs) of women with metastatic breast cancer. (A cell line is a collection of cells that are grown in the laboratory from an original tissue specimen.) The following women may be eligible for this study: * Women who are undergoing cosmetic breast surgery that requires removal of some breast tissue (e.g., breast reduction surgery) * Women 18 years of age or older who are undergoing a biopsy or other surgical procedure to sample or remove a known or suspected primary or metastatic breast tumor * Women 18 years of age or older who are undergoing pleurocentesis, a procedure to remove fluid from around the lung that is suspected or known to be caused by spread of breast cancer Participants undergo the required procedure (e.g., surgery, biopsy, or pleurocentesis) and provide information that may include the following: * Age, race/ethnicity * Age at first menstrual period (menarche) * Age at first pregnancy and age when the first child was born * Age at menopause * Information about primary breast cancer * Family history of breast cancer * Information on previous breast biopsies, if any, and hormones taken (birth control pills or horm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2004-05-27 |
| Est. Completion | 2010-11-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00083733
The ClinicalTrials.gov registry entry for NCT00083733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00083733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00083733 about?
NCT00083733 is a clinical study titled "Genetic and Protein Profiling in Normal and Cancerous Breast Tissue". This study will collect, analyze, and compare genes and proteins in normal breast tissue with those in various tissues from women with breast cancer to look for changes that are unique to breast cancer cells. Information about these differences may lead to more effective breast cancer treatments wit...
What is the current status of trial NCT00083733?
This trial is currently completed. The enrollment target is 216 participants. The study started on 2004-05-27. Estimated completion is 2010-11-17.
Who is sponsoring clinical trial NCT00083733?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.